Bottom line: Like with most drugs, there is variability in how well GLP-1 drugs work across people
GLUCAGON-LIKE PEPTIDE-1 As discussed earlier, glucagon is known to promote hyperglycemia and it seems counterintuitive to use it as treatment in those with diabetes
Performance protocol (10 mg/week) produces faster body composition changes
For inhalers, auto-injectors, and pre-filled syringe products where device patents have been listed in the Orange Book, the FTCs position is that those patents do not claim the drug as required by statute
According to Stat s sources, the case drew the interest of top health officials, suggesting the person receiving the drug was well connected. The patient gained access to the drug through the FDAs compassionate use program, which is usually reserved for patients with serious and life-threatening medical issues, per Stat
Approximately 70% of participants lost at least 5% or more body weight after 12 months with the highest dose of Qsymia